U.S. Markets close in 4 hrs 36 mins

Osiris Therapeutics, Inc. (OSIR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.36-0.09 (-1.65%)
As of 11:08AM EDT. Market open.
People also watch
CYTXCURPSTIOPXAVNDA
  • M
    Mike
    Mike

    Osiris Therapeutics's President & CEO was just granted 25,000 options https://t.co/S1awRrp6fF $OSIR

  • o
    ozark580
    ozark580
    Here is the Veterans Administration (VA) 2017 sales score between EpiFix and Grafix:

    From January 1, 2017 through September 18, 2017

    EpiFix $1,474,712 (but, according to the latest news stories...with possible channel stuffing)
    Grafix $ 717,581

    Osiris is doing just fine with the VA!
  • T
    Techfan20
    Techfan20
    $OSIR freeze dried product is coming

    "Experience in Formulation of biopharmaceutical product and lyophilization cycle optimization is a plus."
    Careers - Osiris Therapeutics, Inc.
    jobs-osiris.icims.com
  • a
    ativaloc
    ativaloc

    Poor Pete Pepity maybe doing some jail time

    http://www.aureliusvalue.com/research/mimedx-flying-close-sun/

    MiMedx: Flying Too Close To The Sun - Aurelius Value
    We see large undiscounted channel stuffing and kickback risks lurking beneath the surface at MiMedx (NASDAQ: MDXG)
    www.aureliusvalue.com
  • A
    Anonymous
    Anonymous
    Looking for OSIR and My Oh My Medex to swap market caps.
  • A
    Anonymous
    Anonymous
    As awful as this dragging on is, I foresee many HUGE parties when we get up-to-date (and re-listed.) . Just saying folks!
  • S
    Stars Stripes
    Stars Stripes
    I know one thing that I am 100% sure of, all those Sundays I was told and brought up to be patient and pray has been put to the test for this stock, Amen !!
  • M
    Mike
    Mike
    Well only 8 trading days left till something has to happen as I believe Oct 3rd was last day given to deliver financials. Was so hoping it would be today. Would think at least they could give an update. But we should know soon enough.
  • P
    Pivalde
    Pivalde
    Difficult to give options without exact info and that info is only in the books. Looks like E&Y has done it's work by now. The board has evidently seen the books and had their official meeting yesterday. So they must have accepted the books and perhaps thought what follows: proposals for annular meetings including the publishing the books etc. Only my hope all this happened yesterday.
  • S
    Stars Stripes
    Stars Stripes
    Maybe they follow up tonight, at least they are alive !
  • m
    minnesotafarmcountry
    minnesotafarmcountry
    Getting frustrated ... throw us a freakin' bone!!
  • a
    ativaloc
    ativaloc
    SEE WHO'S ATTENDING On October 4-6, we will hear what OSIRIS has to say.
    The 2017 Cell & Gene Meeting on the Mesa is only two weeks away! Leaders from the following companies and organizations will be in La Jolla on October 4-6, will you? Register now to secure your place at the cell and gene therapy sector's premier annual conference.

    4D Molecular Therapeutics
    AABB
    Abeona Therapeutics
    ACF Bioservices
    Acucela
    Adaptimmune
    Adjuvant Partners
    Adverum Biotechnologies
    AGTC
    Ajinomoto North America
    Akron Biotech
    Aldevron
    All India Institute of Medical Sciences
    AllCells
    Allergan
    Alliance for Regenerative Medicine
    AlloSource
    American Gene Technologies
    Amnion Foundation
    Anthem
    ASBMT
    ASGCT
    Asklepios Biopharmaceutical
    Astellas Pharma
    Asterias Biotherapeutics
    Atara Biotherapeutics
    Athersys
    Audentes Therapeutics
    Avectas
    Avery Therapeutics
    AveXis
    AVM Biotechnology
    AVROBIO
    AxoGen
    Bank of America Merrill Lynch
    Baylor University
    Be the Match BioTherapies
    Becton Dickinson
    Beijing Genomics Institute
    Bellicum Pharmaceuticals
    Benitec Biopharma
    BioInsights Publishing
    BioLife Solutions
    Biological Industries USA
    BioMarin
    BioMedGPS
    bioMerieux
    BioreclamationIVT
    Biostage
    BioTime
    BloodCenter of Wisconsin
    Blood Systems
    Bloodworks
    bluebird bio
    BlueRock Therapeutics
    B-MoGen Biotechnologies
    Bone Therapeutics
    Boston Biomedical Associates
    Boston Scientific
    BrainXell
    Brammer Bio
    Brooks Life Science Systems
    BridgeBio Pharma
    Buck Institute for Research on Aging
    CA Department of Public Health
    Cal Poly San Luis Obispo
    Caladrius Biosciences
    Calibr
    Capricor Therapeutics
    CarthaGenetics Suisse Sàrl
    Catalyst Advisors
    CCRM
    Cell and Gene Therapy Catapult
    Cell Innovation Partners Limited
    Cell Medica
    Cell Therapies Pty.
    CellGenix
    Cells for Cells
    CellSeed
    Cellular Dynamics International
    Celsense
    Cesca Therapeutics
    Charter Medical
    Children's Hospital LA
    Chromocenter
    CIRM
    City of Hope
    CJ Partners
    ClearView Healthcare Partners
    Cleveland Clinic Foundation
    CMIC Holdings
    Cognate Bioservices
    College of Engineering, Pune
    CombiGene
    Consulate General of France
    CRISPR Therapeutics
    Cryoport
    CSL Behring
    CSU San Marcos
    CTI Clinical Trial and Consulting
    Cynata Therapeutics
    Cynity
    Cytonome
    D&P Bioinnovations
    Danaher
    DEFTA Partners
    Department of Commerce
    Diamond Pharma Services
    Dignity Health
    DiscGenics
    Dohmen Life Science Services
    Draper
    EBD Group
    Editas Medicine
    EMD Millipore
    ERA Consulting UK
    EUFETS
    Evidera
    Fate Therapeutics
    Fibrocell Science
    FIRM
    Fortress Biotech
    F-Prime Capital
    Fraunhofer Institute
    Fred Hutchinson Cancer Center
    FreeMind Group
    Fresenius Kabi
    GammaDelta Therapeutics
    GE Healthcare
    GenCure
    Genea Biocells
    GenEdit
    George Washington University
    GlaxoSmithKline
    Glycostem
    Gravitas Biomanufacturing
    GSRAC
    H.C. Wainwright
    Harvard University
    HBRI
    Healios K.K.
    Histogenics
    Hitachi
    Holland & Knight
    Homology Medicines
    Hospital Israelita Albert Einstein
    Human Longevity
    Hybrid Concepts
    ICER
    ICS - AmerisourceBergen
    Informa
    Inotek Pharmaceuticals
    Innovative Blood Resources
    Institute for Genomic Medicine
    Integrium
    Intellia Therapeutics
    Invetech
    Irvine Scientific
    ISCT
    ISSCR
    Janssen R&D
    Japanese Society for RM
    jCyte
    Johnson & Johnson
    Juno Therapeutics
    Juventas Therapeutics
    Kawasaki Heavy Industries
    KBI Biopharma
    Kissei America
    Kyoto University
    Lake Street Capital Markets
    LMRI
    LogicBio Therapeutics
    Lonza
    Lovelace Biomedical
    Lung Institute
    Lysogene
    MAK-SYSTEM
    Mallinckrodt
    MaSTherCell
    MaxCyte
    Mayo Clinic
    McKesson
    MedCision
    Medeor Therapeutics
    MEDINET
    MEDIPOST America
    Medpace
    MedPOINT Management
    Medtronic
    Mesoblast
    METI
    MHLW
    Mill Creek Life Sciences
    MilliporeSigma
    MiMedx Group
    MolMed
    Myonexus Therapeutics
    National Marrow Donor Program
    National PKU Alliance
    National Search Associates
    NDA Advisory Services
    NDRI
    New York Blood Center
    NIH
    Nikon Cell Innovation
    Nohla Therapeutics
    Novadip Biosciences
    Novartis
    Novasep
    NSVascular
    NuTech Medical
    NYSCF
    Oklahoma Blood Institute
    Olympus
    Opsis Therapeutics
    Orbsen Therapeutics
    Orchard Therapeutics
    Organovo
    ORIG3N
    Osiris Therapeutics
    Oxford BioMedica
    Pall Life Sciences
    Parker Hannifin
    PCT
    Pepper Hamilton
    PersImmune
    Pfizer
    Phacilitate
    PharmaCell
    PMDA
    PMI Preclinical
    POC Clinical Research
    Precision BioSciences
    Prevail Partners
    Promethera Biosciences
    Propagenix
    Pukana Partners
    Qiming Venture Partners
    Quad Technologies
    QuintilesIMS
    Regenerex
    Regeneron
    REGENXBIO
    ReNeuron
    Renova Therapeutics
    ReproCELL
    RLB Consulting
    ROHTO Pharmaceutical
    RoosterBio
    Roslin Cell Therapies
    RTW Investments
    RxGen
    Salk Institute for Biological Studies
    San Diego State University
    San Diego Union Tribune
    San Diego Zoo Institute
    San Raffaele Telethon Institute
    SanBio
    Sanford Burnham Prebys
    Sanford Consortium
    Sangamo Therapeutics
    Sanofi
    Santa Fe Christian School
    Sapporo Medical University
    Sartorius Stedim Biotech
    Save The Cord Foundation
    SAVSU Technologies
    Scinogy
    SCM Lifescience
    Scottish Development International
    Scrip/The Pink Sheet
    Semma Therapeutics
    SENS Research Foundation
    Sentien Biotechnologies
    SERVA Electrophoresis
    Shire
    Sigilon Therapeutics
    Sistemic Limited
    Southland Corporation
    Spark Therapeutics
    Stanford University
    StemBios Technologies
    StemBioSys
    Steminent Biotherapeutics
    StemoniX
    Sumitomo Dainippon Pharma
    Summit for Stem Cell Foundation
    Supporting Science
    Switch Bio
    Synpromics
    Takeda Pharmaceuticals
    Terumo BCT
    Texas Biomedical Research Institute
    The Scripps Research Institute
    Thermo Fisher Scientific
    ThinkCyte
    TiGenix
    Tmunity Therapeutics
    Tolley Health Economics
    Torrey Pines Institute
    TrakCel
    Triumvira Immunologics
    Tucson Medical Center
    Tulane University
    TxCell
    UC Berkeley
    UC Irvine
    UC San Diego
    UK Dept. for International Trade
    uniQure
    Universal Cells
    University of Arizona
    University of Massachusetts
    University of Michigan
    University of Notre Dame
    University of Oklahoma
    University of Oxford
    University of Pennsylvania
    US Army Institute
    US Food and Drug Administration
    USC
    Vericel
    VeriGraft
    Versant Ventures
    ViaCyte
    Vineti
    Vivet Therapeutics
    Voisin Consulting
    Voyager Therapeutics
    W.L. Gore & Associates
    Weill Cornell Medicine
    Weizmann Institute
    WindMIL Therapeutics
    WIRB-Copernicus Group
    World Courier
    WuXi AppTec
    Wyss Institute
    Xenco Medical
    Xintela AB
    Yale School of Medicine
    YposKesi
  • S
    Stars Stripes
    Stars Stripes
    OSIR could be the biggest comeback ever for any company, from $3 to $100 in 2 years, can I get a BOOOOYAAAAA !!!!
  • r
    roy
    roy
    CEOs option were granted on July 10, but Osiris chose to disclose them now. This is not imo a coincidence. Other filings will follow shortly.
  • T
    Techfan20
    Techfan20
    While we wait on EY to complete the $OSIR audit, take @biotechfan20 twitter poll on when we think they will report
    @biotechfan20 - Búsqueda de Twitter
    Los Tweets más recientes de @biotechfan20. Lee lo que las personas están diciendo y únete a la conversación.
    twitter.com
  • T
    Techfan20
    Techfan20
    Stryker($SYK) promoting use of $OSIR BIO4 for interbody spinal fusion

    az621074.vo.msecnd. net/syk-mobile-content-cdn/global-content-system/SYKGCSDOC-2-46167/v3bH5Tsn1KjHQjCjSiRj8INrqo8Nlw/TLX45_BR_1.pdf
  • t
    tim
    tim
    Anyone think Aziyos' ViBone resembles BIO4? yhoo will not let me post link
  • T
    Techfan20
    Techfan20
    Osiris is searching for Surgical Sales Specialists in Dallas, Madison WI, Utah, and Northern CA
    Careers - Osiris Therapeutics, Inc.
    jobs-osiris.icims.com
  • S
    Stars Stripes
    Stars Stripes
    I sure don't trust Aziyos, they just bought out CorMax with a new sales force. I tried posting the link, it was deleted.